LBP-SA01

N/A

Report date: 2024/03/04 16:09:47

Base Information

Drug NameLBP-SA01
Drug Alias NameLBP-SA01
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionBacterial DNA gyrase degradersCell death stimulants
TargetsBacterial DNA gyrase
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLocus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals IncLocus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A